Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 11:04 am Purchase | 2025-09-30 | 13G | Royalty Pharma plc RPRX | Capital International Investors | 28,512,128 6.600% | 5,400,130 (+23.37%) | Filing History |
| 2025-11-05 11:44 am Sale | 2025-09-30 | 13G | Royalty Pharma plc RPRX | FMR LLC | 27,900,714 6.500% | -11,344,879 (-28.91%) | Filing History |
| 2025-10-30 3:48 pm Sale | 2025-09-30 | 13G | Royalty Pharma plc RPRX | VANGUARD GROUP INC | 10,936,538 2.520% | -27,060,984 (-71.22%) | Filing History |
| 2025-08-14 08:30 am Sale | 2025-06-30 | 13G | Royalty Pharma plc RPRX | GENERAL ATLANTIC L.P. | 14,243,870 3.200% | -12,015,271 (-45.76%) | Filing History |
| 2025-08-13 12:49 pm Purchase | 2025-06-30 | 13G | Royalty Pharma plc RPRX | Capital International Investors | 23,111,998 5.500% | 23,111,998 (New Position) | Filing History |
| 2025-08-05 11:56 am Purchase | 2025-06-30 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 38,907,011 9.200% | 2,389,852 (+6.54%) | Filing History |
| 2025-05-23 5:05 pm Purchase | 2025-05-16 | 13D | Royalty Pharma plc RPRX | Legorreta Pablo G. | 103,112,796 19.740% | 103,112,796 (New Position) | Filing History |
| 2025-05-12 10:39 am Purchase | 2025-03-31 | 13G | Royalty Pharma plc RPRX | FMR LLC | 39,245,593 9.100% | 12,936,266 (+49.17%) | Filing History |
| 2025-05-02 6:19 pm Sale | 2025-04-30 | 13D | Royalty Pharma plc RPRX | Severgnini Achille G. | 29,926,170 6.900% | -6,075,365 (-16.88%) | Filing History |
| 2025-02-21 4:30 pm Sale | 2025-02-19 | 13D | Royalty Pharma plc RPRX | Severgnini Achille G. | 36,001,535 8.300% | -5,649,635 (-13.56%) | Filing History |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | Royalty Pharma plc RPRX | FMR LLC | 26,309,327 5.900% | -5,274,599 (-16.70%) | Filing History |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | Royalty Pharma plc RPRX | BlackRock Inc. BLK | 25,445,414 5.700% | 25,445,414 (New Position) | Filing History |
| 2024-11-08 3:15 pm Sale | 2024-09-30 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 36,517,159 8.200% | -4,642,590 (-11.28%) | Filing History |
| 2024-07-29 4:30 pm Purchase | 2024-07-09 | 13D | Royalty Pharma plc RPRX | Severgnini Achille G. | 41,651,170 13.000% | 41,651,170 (New Position) | Filing History |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | Royalty Pharma plc RPRX | VANGUARD GROUP INC | 37,997,522 8.540% | 2,369,731 (+6.65%) | Filing History |
| 2024-02-13 10:17 am Purchase | 2023-12-31 | 13G | Royalty Pharma plc RPRX | GENERAL ATLANTIC L.P. | 26,259,141 5.600% | 14,400 (+0.05%) | Filing History |
| 2024-02-09 3:13 pm Sale | 2023-12-31 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 41,159,749 9.200% | -2,615,649 (-5.98%) | Filing History |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Royalty Pharma plc RPRX | FMR LLC | 31,583,926 7.099% | -12,526,439 (-28.40%) | Filing History |
| 2023-02-13 4:53 pm Purchase | 2022-12-31 | 13G | Royalty Pharma plc RPRX | GENERAL ATLANTIC L.P. | 26,244,741 5.600% | 871 (+0.00%) | Filing History |
| 2023-02-10 3:21 pm Sale | 2022-12-30 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 43,775,398 9.900% | -12,235,612 (-21.85%) | Filing History |